Thalidomide produces transfusion independence in long-standing refractory anemias of patients with myelodysplastic syndromes. - Raza,A.; Meyer,P.; Dutt,D.; Zorat,F.; Lisak,L.; Nascimben,F.; du Randt,M.; Kaspar,C.; Goldberg,C.; Loew,J.; Dar,S.; Gezer,S.; et al. (Blood, 2001)